Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Michael Laska"'
Autor:
Christina Chaivorapol, Chamith Fonseka, Terry J. Fry, Shirisha Amatya, Zach Frye, Saurabh Paliwal, Jagesh V Shah, Samantha Davis, Patricia Cruite, Christopher Bandoro, Hina Iftikhar, Nikolas Balanis, Michael Laska, Lauren Pepper
Publikováno v:
Blood. 138:3983-3983
Introduction: The ability to deliver genes to specific cell types in vivo would have a profound therapeutic impact for a diverse set of diseases. For example, targeting T cells for in vivo delivery of a chimeric antigen receptor (CAR) to treat B cell
Autor:
Heather Jewell, Akinola Olumide Emmanuel, Albert Ruzo, Boris Gorovits, Caspian Harding, Bindu Varghese, Yonatan Lipsitz, Vidur Patel, Justine Cunningham, Sundeep Chandra, Victoria Duback, Hemant Chavan, Joohwan Kim, Michelle Nguyen-McCarty, Shannon Joyce, Aaron E. Foster, Carmela Passaro, Sergey Lyubinetsky, Lauren Pepper, Jason Rodriguez, Trevor McGill, Kelan Hlavaty, Misha Shamashkin, Paige Baldwin, Terry J. Fry, Shirisha Amatya, Carl Co, Salvatore Iovino, Jagesh V Shah, Hanane Ennajdaoui, Jess Elman, Allyse Mazzarelli, Donna Dambach, Kutlu G. Elpek, Carrie Rocca, Vasily Vagin, James Kaczmarek, Pattie Cruite, Michael Laska
Publikováno v:
Blood. 138:2769-2769
Introduction: Ex vivo manufactured chimeric antigen receptor (CAR) T cell therapies are highly effective for treating B cell malignancies. However, the complexity, cost and time required to manufacture CAR T cells limits access. To overcome conventio
Autor:
Sergey Lyubinetsky, Allyse Mazarelli, Jess Elman, Kutlu G. Elpek, Patty Cruite, Caspian Harding, Trevor McGill, Donna Dambach, Terry J. Fry, Salvatore Iovino, Carmela Passaro, Vidur Patel, Shirisha Amatya, Albert Ruzo, Kelan Hlavaty, Victoria Duback, Lauren Pepper, Anna Liang, Avani Parikh, Akinola Olumide Emmanuel, Jagesh V Shah, Samantha Crocker, Michael Laska, Jason Rodriguez, Hanane Ennajdaoui, Paige Baldwin
Publikováno v:
Cancer Research. 81:LB105-LB105
CAR T cells are highly effective at inducing remissions in patients with refractory B cell malignancies. The ex vivo process used to manufacture these therapies limits patient access and exposes T cells to non-physiologic conditions in culture. Viral
Autor:
Michael Laska
Publikováno v:
Mathematics of Computation. 38:257-260
Let E be an elliptic curve defined over an algebraic number field K and assume that some Weierstrass equation for E over K is given. Then an algorithm is described which yields a global minimal Weierstrass equation for E over K provided such a global
Autor:
Michael Laska
Publikováno v:
Archiv der Mathematik. 44:159-167
Autor:
Michael Laska
Publikováno v:
Archiv der Mathematik. 31:232-234
Autor:
Michael Laska
Publikováno v:
Elliptic Curves over Number Fields with Prescribed Reduction Type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::454b80b34ecc3abc1412afda7f98c490
https://doi.org/10.1007/978-3-322-87599-0
https://doi.org/10.1007/978-3-322-87599-0
Autor:
Michael Laska
Publikováno v:
Elliptic Curves over Number Fields with Prescribed Reduction Type ISBN: 9783528085698
The set E(S) of all elliptic curves over K with good reduction outside a finite set of prime ideals S in OK and the division into isogeny classes has explicitly been determined for several concrete choices of K and S. In most cases E(S) is obtained b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14483cbdaebe113a22d50c87c4c2eeeb
https://doi.org/10.1007/978-3-322-87599-0_6
https://doi.org/10.1007/978-3-322-87599-0_6
Autor:
Michael Laska
Publikováno v:
Elliptic Curves over Number Fields with Prescribed Reduction Type ISBN: 9783528085698
In this chapter we give an explicit parametrization in terms of a certain diophantine equation over K of all elliptic curves over K with good reduction outside a given finite set of prime ideals in OK.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::875b7469ef1e10c4c6eb40debf5552d6
https://doi.org/10.1007/978-3-322-87599-0_3
https://doi.org/10.1007/978-3-322-87599-0_3